$ACTG Cashflow Statement | Understand Stock

$ACTG

$4.16 -$0.05 (1.19%) Close

$ACTG Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Unaudited condensed consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net income (loss) including noncontrolling interests in subsidiaries
Adjustments to reconcile net income (loss) including noncontrolling interests in subsidiaries to net cash provided by operating activities:
Change in fair value of investment
Gain on sale of investment
Depreciation, depletion and amortization
Amortization of debt discount and issuance costs
Accretion of asset retirement obligation
Change in fair value of Series A redeemable convertible preferred stock embedded derivatives
Change in fair value of Series A warrants
Change in fair value of Series B warrants
Loss on exercise of Series A warrants
Gain on exercise of Series B warrants
Loss on disposal of assets
Compensation expense for share-based awards
(Gain) loss on foreign currency exchange
Change in fair value of equity securities
Loss (gain) on sale of equity securities
Earnings on equity investment in joint venture
Unrealized (gain) loss on derivatives
Deferred income taxes
Changes in operating assets and liabilities:
Accounts receivable
Inventories
Prepaid expenses and other assets
Accounts payable and accrued expenses
Royalties and contingent legal fees payable
Deferred revenue
Deferred income tax liabilities

Net cash provided by operating activities
Cash flows from investing activities:
Acquisition, net of cash acquired and working capital adjustments (Note 3)
Cash reinvested
Patent acquisition
Proceeds from sale of floor mat assets
Purchases of equity securities
Sales of equity securities
Maturities and sales of debt securities
Distributions received from equity investment in joint venture
Distributions to noncontrolling interests in operating subsidiary
Net purchases of property and equipment and additions to oil and gas properties
Purchases of loans receivable
Purchases of property and equipment
Net additions to oil and gas properties
Net cash used in investing activities

Cash flows from financing activities:
Repurchase of common stock
Issuance of Senior Secured Notes, net of lender fee
Paydown of Senior Secured Notes
Contributions from noncontrolling interest
Borrowings on the Benchmark revolving credit facility
Paydown of Benchmark revolving credit facility
Borrowings on the Deflecto Facility
Paydown of Deflecto Facility
Senior Secured Notes issuance costs paid to other parties
Dividend on Series A Redeemable Convertible Preferred Stock
Issuance of Series B warrants
Taxes paid related to net share settlement of share-based awards
Proceeds from exercise of stock options
Net cash (used in) provided by financing activities
Increase in cash and cash equivalents and restricted cash

Effect of exchange rates on cash and cash equivalents
Increase (decrease) in cash and cash equivalents
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period
Supplemental schedule of cash flow information:
Interest paid
Income taxes paid, net
Noncash investing and financing activities:
Accrued patent costs
Distribution to noncontrolling interests in subsidiaries
Cash distributed for notes receivable
Acquisition of Life Sciences Portfolio equity securities
Operating lease right-of-use assets obtained in exchange for lease liabilities
Derecognition of operating lease right-of-use assets upon lease termination
Derecognition of operating lease liabilities upon lease termination
Patent acquisition of prepaid option

Comments